A.M. Palache

4.8k total citations
59 papers, 3.4k citations indexed

About

A.M. Palache is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, A.M. Palache has authored 59 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 19 papers in Immunology and 16 papers in Infectious Diseases. Recurrent topics in A.M. Palache's work include Influenza Virus Research Studies (50 papers), Respiratory viral infections research (25 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). A.M. Palache is often cited by papers focused on Influenza Virus Research Studies (50 papers), Respiratory viral infections research (25 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). A.M. Palache collaborates with scholars based in Netherlands, Belgium and Switzerland. A.M. Palache's co-authors include W.E.P. Beyer, Albert D. M. E. Osterhaus, J.C. de Jong, N. Masurel, Guus F. Rimmelzwaan, Jan Wilschut, Iris A. de Bruijn, G.J.M. van Scharrenburg, J. J. P. Nauta and Ruud Brands and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Annals of the Rheumatic Diseases.

In The Last Decade

A.M. Palache

58 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Palache Netherlands 33 2.7k 1.1k 818 453 420 59 3.4k
Katja Höschler United Kingdom 31 3.6k 1.3× 1.4k 1.2× 1.9k 2.3× 508 1.1× 292 0.7× 96 4.9k
N. Masurel Netherlands 33 2.4k 0.9× 727 0.6× 667 0.8× 239 0.5× 201 0.5× 106 3.0k
Changgui Li China 23 1.3k 0.5× 520 0.5× 1.7k 2.1× 447 1.0× 540 1.3× 99 2.9k
Olav Hungnes Norway 30 2.1k 0.8× 509 0.4× 1.0k 1.3× 504 1.1× 95 0.2× 86 3.0k
Karen Laurie Australia 31 1.9k 0.7× 975 0.9× 634 0.8× 307 0.7× 57 0.1× 74 2.5k
Matthew J. Memoli United States 29 1.6k 0.6× 548 0.5× 997 1.2× 465 1.0× 74 0.2× 53 2.6k
Natalie Pica United States 20 2.0k 0.7× 967 0.8× 559 0.7× 482 1.1× 45 0.1× 21 2.7k
Nicholas S. Kelley United States 6 1.6k 0.6× 346 0.3× 598 0.7× 217 0.5× 379 0.9× 10 2.1k
Fatima Amanat United States 27 1.0k 0.4× 640 0.6× 2.8k 3.4× 531 1.2× 263 0.6× 55 3.8k
Aneesh K. Mehta United States 33 1.7k 0.6× 1.4k 1.2× 2.0k 2.4× 652 1.4× 79 0.2× 90 4.4k

Countries citing papers authored by A.M. Palache

Since Specialization
Citations

This map shows the geographic impact of A.M. Palache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Palache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Palache more than expected).

Fields of papers citing papers by A.M. Palache

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Palache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Palache. The network helps show where A.M. Palache may publish in the future.

Co-authorship network of co-authors of A.M. Palache

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Palache. A scholar is included among the top collaborators of A.M. Palache based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Palache. A.M. Palache is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palache, A.M., et al.. (2023). Lessons learned from the COVID-19 pandemic for improved influenza control. Vaccine. 41(40). 5877–5883. 4 indexed citations
2.
3.
4.
5.
6.
7.
Holvast, Albert, Sander van Assen, Anke Huckriede, et al.. (2009). Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Lara D. Veeken. 48(10). 1294–1299. 30 indexed citations
8.
Holvast, Albert, Sander van Assen, Aalzen de Haan, et al.. (2009). Studies of cell‐mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis & Rheumatism. 60(8). 2438–2447. 42 indexed citations
9.
Holvast, Albert, Sander van Assen, Aalzen de Haan, et al.. (2008). Antibody and cell-mediated responses to influenza vaccination in patients with systemic lupus erythematosus and, healthy controls. Data Archiving and Networked Services (DANS). 58(9).
10.
Holvast, Albert, Coen A. Stegeman, C. A. Benne, et al.. (2008). Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination. Annals of the Rheumatic Diseases. 68(6). 873–878. 52 indexed citations
11.
Bruijn, Iris A. de, et al.. (2005). Clinical experience with inactivated, virosomal influenza vaccine. Vaccine. 23. S39–S49. 40 indexed citations
12.
Huckriede, Anke, Laura Bungener, Toon Stegmann, et al.. (2005). The virosome concept for influenza vaccines. Vaccine. 23. S26–S38. 190 indexed citations
13.
Medema, Jan Paul, York Zoellner, James A. Ryan, & A.M. Palache. (2004). Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply. Virus Research. 103(1-2). 9–15. 23 indexed citations
14.
Oxford, John, Ali A. Al‐Jabri, Rob Lambkin‐Williams, A.M. Palache, & Douglas Fleming. (2003). Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine. Vaccine. 21(21-22). 2743–2746. 12 indexed citations
15.
Stephenson, Iain, Karl G. Nicholson, Robert Mischler, et al.. (2003). Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. The Lancet. 362(9400). 1959–1966. 124 indexed citations
16.
Huckriede, Anke, Laura Bungener, Wouter ter Veer, et al.. (2003). Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity. Vaccine. 21(9-10). 925–931. 43 indexed citations
17.
Beyer, W.E.P., A.M. Palache, J.C. de Jong, & Albert D. M. E. Osterhaus. (2002). Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. Vaccine. 20(9-10). 1340–1353. 197 indexed citations
18.
Beyer, W.E.P., A.M. Palache, René Kerstens, & N. Masurel. (1996). Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. European Journal of Clinical Microbiology & Infectious Diseases. 15(1). 65–70. 72 indexed citations
19.
Palache, A.M.. (1991). Influenza vaccination : the effect of dose and age on the antibody response : a methodological evaluation of serological vaccination studies.. Data Archiving and Networked Services (DANS). 8 indexed citations
20.
Beyer, W.E.P., et al.. (1989). Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine. 7(5). 385–394. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katja Höschler Breakdown of academic impact, for papers by N. Masurel Breakdown of academic impact, for papers by Changgui Li Breakdown of academic impact, for papers by Olav Hungnes Breakdown of academic impact, for papers by Karen Laurie Breakdown of academic impact, for papers by Matthew J. Memoli Breakdown of academic impact, for papers by Natalie Pica Breakdown of academic impact, for papers by Nicholas S. Kelley Breakdown of academic impact, for papers by Fatima Amanat Breakdown of academic impact, for papers by Aneesh K. Mehta
Rankless by CCL
2026